UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas

Journal of magnetic resonance imaging, 2016-08, Vol.44 (2), p.456-462

2016

Volltextzugriff (PDF)

Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions

Neuro-oncology (Charlottesville, Va.), 2020-09, Vol.22 (9), p.1368-1378

2020

Volltextzugriff (PDF)

Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic

Neuro-oncology (Charlottesville, Va.), 2020-04, Vol.22 (7), p.912-917

2020

Volltextzugriff (PDF)

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (11), p.1827-1844

2022

Volltextzugriff (PDF)

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1669-1675

2016

Volltextzugriff (PDF)

Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging

Magnetic resonance in medicine, 2008-10, Vol.60 (4), p.842-849

2008

Volltextzugriff (PDF)

Tissue concentration of systemically administered antineoplastic agents in human brain tumors

Journal of neuro-oncology, 2011-09, Vol.104 (3), p.629-638

2011

Volltextzugriff (PDF)

Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria

American journal of medical genetics. Part A, 2013-03, Vol.161A (3), p.405-416

2013

Volltextzugriff (PDF)

Precision Oncology for Papillary Craniopharyngioma

The New England journal of medicine, 2023-07, Vol.389 (2), p.179-181

2023

Volltextzugriff (PDF)

Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors

Cancers, 2022-06, Vol.14 (12), p.3015

2022

Volltextzugriff (PDF)

Spectrum and Prevalence of Vasculopathy in Pediatric Neurofibromatosis Type 1

Journal of child neurology, 2013-05, Vol.28 (5), p.561-569

2013

Volltextzugriff (PDF)

Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients

NeuroImage clinical, 2022-01, Vol.35, p.103121-103121, Article 103121

2022

Volltextzugriff (PDF)

Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study

Journal of neuro-oncology, 2009-01, Vol.91 (1), p.51-58

2009

Volltextzugriff (PDF)

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations

Neuro-oncology (Charlottesville, Va.), 2016-03, Vol.18 Suppl 2 (suppl 2), p.ii13-ii20

2016

Volltextzugriff (PDF)

Cutaneous Manifestations in Neuro-Oncology: Clinically Relevant Tumor and Treatment Associated Dermatologic Findings

Seminars in oncology, 2016-06, Vol.43 (3), p.401-407

2016

Volltextzugriff (PDF)

Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors

EMBO molecular medicine, 2020-01, Vol.12 (1), p.e11656-n/a

2020

Volltextzugriff (PDF)

Hearing and facial function outcomes for neurofibromatosis 2 clinical trials

Neurology, 2013-11, Vol.81 (21 Suppl 1), p.S25

2013

Volltextzugriff (PDF)

Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

Neuro-oncology (Charlottesville, Va.), 2016-05, Vol.18 (5), p.624-638

2016

Volltextzugriff (PDF)

Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

Neurology, 2019-09, Vol.93 (11), p.e1076

2019

Volltextzugriff (PDF)

Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase-mutant Astrocytic and Oligodendroglial Tumors

Clinical cancer research, 2023-12, Vol.29 (23), p.4863-4869

2023

Volltextzugriff (PDF)

Selumetinib in Children with Inoperable Plexiform Neurofibromas

The New England journal of medicine, 2020-04, Vol.382 (15), p.1430-1442

2020

Volltextzugriff (PDF)

Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

Neurology, 2019-09, Vol.93 (11)

2019

Volltextzugriff (PDF)

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas

Laryngoscope investigative otolaryngology, 2021-10, Vol.6 (5), p.1008-1019

2021

Volltextzugriff (PDF)

Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis

Skeletal radiology, 2020-02, Vol.49 (2), p.199-219

2020

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(148)
Bücher
(2)

Sprache

Englisch
(149)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas

Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions

Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas

Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas

Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging

Tissue concentration of systemically administered antineoplastic agents in human brain tumors

Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria

Precision Oncology for Papillary Craniopharyngioma

Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors

Spectrum and Prevalence of Vasculopathy in Pediatric Neurofibromatosis Type 1

Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients

Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations

Cutaneous Manifestations in Neuro-Oncology: Clinically Relevant Tumor and Treatment Associated Dermatologic Findings

Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors

Hearing and facial function outcomes for neurofibromatosis 2 clinical trials

Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase-mutant Astrocytic and Oligodendroglial Tumors

Selumetinib in Children with Inoperable Plexiform Neurofibromas

Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas

Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis

Suchergebnisse filtern